Inventor · disambiguated record
Olivier Duclos
Also filed as: DUCLOS OLIVIER
21 granted patents·4 pending applications·57 citations·filing 2009–2023
93Inventor score
Top patents by PatentIndex Score
25 records- 0185US10961295B2Modified lipidated Relaxin B chain peptides and their therapeutic useSANOFI SA·Filed 2019·Granted Mar 30, 2021·2 cites·23 claims
- 0285US9744176B2Therapeutic uses of novel thienopyrimidine derivativesSANOFI SA·Filed 2015·Granted Aug 29, 2017·4 cites·23 claims
- 0383US10220044B2Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereofSANOFI SA·Filed 2017·Granted Mar 5, 2019·3 cites·1 claims
- 0483US9115140B2Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereofSANOFI SA·Filed 2013·Granted Aug 25, 2015·5 cites·15 claims
- 0582US10500212B2Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereofSANOFI SA·Filed 2019·Granted Dec 10, 2019·2 cites·1 claims
- 0681US9169246B2Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereofBENAZET ALEXANDRE·Filed 2011·Granted Oct 27, 2015·18 cites·14 claims
- 0779US10988524B2Modified relaxin B chain peptides and their therapeutic useSANOFI SA·Filed 2019·Granted Apr 27, 2021·2 cites·20 claims
- 0876US8686150B26-(4-hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitorsSANOFI SA·Filed 2012·Granted Apr 1, 2014·3 cites·11 claims
- 0976US8541449B2Substituted isoquinolines and isoquinolinones as Rho kinase inhibitorsPLETTENBURG OLIVER·Filed 2009·Granted Sep 24, 2013·3 cites·50 claims
- 1076US8470847B2Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeuticsALAM ANTOINE·Filed 2009·Granted Jun 25, 2013·5 cites·12 claims
- 1176US8263614B2Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeuticsALAM ANTOINE·Filed 2009·Granted Sep 11, 2012·3 cites·10 claims
- 1275US2024218042A1Modified lipidated relaxin b chain peptides and their therapeutic useSANOFI SA·Filed 2023·Application pending·0 cites
- 1374US10988523B2Modified lipidated Relaxin B chain peptides and their therapeutic useSANOFI SA·Filed 2019·Granted Apr 27, 2021·2 cites·20 claims
- 1471US10980816B2Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereofSANOFI SA·Filed 2020·Granted Apr 20, 2021·0 cites·1 claims
- 1570US10736904B2Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereofSANOFI SA·Filed 2019·Granted Aug 11, 2020·0 cites·2 claims
- 1668US9126972B22-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitorsBRAUN ALAIN·Filed 2012·Granted Sep 8, 2015·3 cites·19 claims
- 1767US11725036B2Modified lipidated relaxin B chain peptides and their therapeutic useSANOFI SA·Filed 2020·Granted Aug 15, 2023·0 cites·3 claims
- 1861US8846712B26-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitorsLOEHN MATTHIAS·Filed 2011·Granted Sep 30, 2014·2 cites·7 claims
- 1950US8524737B2Bi- and polycyclic substituted isoquinoline and isoquinolinone derivativesPLETTENBURG OLIVER·Filed 2009·Granted Sep 3, 2013·0 cites·37 claims
- 2049US8710077B2Cycloalkylamine substituted isoquinoline and isoquinolinone derivativesPLETTENBURG OLIVER·Filed 2009·Granted Apr 29, 2014·0 cites·47 claims
- 2143US2014235616A1Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereofSANOFI SA·Filed 2012·Application pending·0 cites
- 2240US9675606B22-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitorsSANOFI SA·Filed 2015·Granted Jun 13, 2017·0 cites·17 claims
- 2339US2011251194A1Antineoplastic derivatives, preparation thereof and therapeutic use thereofSANOFI AVENTIS·Filed 2011·Application pending·0 cites
- 2433US2013178472A1Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereofBELLEVERGUE PATRICE·Filed 2012·Application pending·0 cites
- 2528US8975250B25 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseasesBEAUVERGER PHILIPPE·Filed 2012·Granted Mar 10, 2015·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Olivier Duclos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →